PT

Peter Turecek

BI Baxalta Incorporated: 9 patents #1 of 106Top 1%
NT Nektar Therapeutics: 2 patents #14 of 64Top 25%
Overall (2016): #7,979 of 481,213Top 2%
9
Patents 2016

Issued Patents 2016

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
9512172 Ethanol dependence of alpha1 antitrypsin C-terminal Lys truncation by basic carboxypeptidases Peter Matthiessen, Alfred Weber, Hans-Peter Schwarz 2016-12-06
9493544 Von willebrand factor- and factor VIII-polymer conjugates having a releasable linkage Mary J. Bossard, Gayle Stephenson, Zhihao Fang, Harold Zappe, Stacy Mitchell +5 more 2016-11-15
9492555 Nucleophilic catalysts for oxime linkage Stefan Haider, Andreas Ivens, Hanspeter Rottensteiner, Juergen Siekmann 2016-11-15
9488651 Methods of measuring ADAMTS 13 activity Katalin Varadi, Hanspeter Rottensteiner, Hans-Peter Schwarz, Jutta Schreiner 2016-11-08
9351935 Stabilized liquid and lyophilized ADAMTS13 formulations Peter Matthiessen, Hans-Peter Schwarz 2016-05-31
9309506 Composition exhibiting a von Willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV Bernhard Laemmle, Helena Elisabeth Schaller-Gerritsen, Miha Furlan, Hans-Peter Schwarz, Friedrich Scheiflinger +4 more 2016-04-12
9274122 Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation) Katalin Varadi, Gerald Schrenk, Hanspeter Rottensteiner, Alfred Weber, Heinz Anderle +5 more 2016-03-01
9272021 Treatment of coagulation disease by administration of recombinant VWF Friedrich Scheiflinger, Bruce Ewenstein, Wing Yen Wong, Tobias M. Suiter 2016-03-01
9265791 Resorption enhancers as additives to improve the oral formulation of low molecular weight heparins Susanne Vejda 2016-02-23